Literature DB >> 27840320

Mitochondrial catalase overexpressed transgenic mice are protected against lung fibrosis in part via preventing alveolar epithelial cell mitochondrial DNA damage.

Seok-Jo Kim1, Paul Cheresh1, Renea P Jablonski1, Luisa Morales-Nebreda1, Yuan Cheng1, Erin Hogan1, Anjana Yeldandi2, Monica Chi1, Raul Piseaux3, Karen Ridge1, C Michael Hart4, Navdeep Chandel3, G R Scott Budinger1, David W Kamp5.   

Abstract

RATIONALE: Alveolar epithelial cell (AEC) injury and mitochondrial dysfunction are important in the development of lung fibrosis. Our group has shown that in the asbestos exposed lung, the generation of mitochondrial reactive oxygen species (ROS) in AEC mediate mitochondrial DNA (mtDNA) damage and apoptosis which are necessary for lung fibrosis. These data suggest that mitochondrial-targeted antioxidants should ameliorate asbestos-induced lung.
OBJECTIVE: To determine whether transgenic mice that express mitochondrial-targeted catalase (MCAT) have reduced lung fibrosis following exposure to asbestos or bleomycin and, if so, whether this occurs in association with reduced AEC mtDNA damage and apoptosis.
METHODS: Crocidolite asbestos (100µg/50µL), TiO2 (negative control), bleomycin (0.025 units/50µL), or PBS was instilled intratracheally in 8-10 week-old wild-type (WT - C57Bl/6J) or MCAT mice. The lungs were harvested at 21d. Lung fibrosis was quantified by collagen levels (Sircol) and lung fibrosis scores. AEC apoptosis was assessed by cleaved caspase-3 (CC-3)/Surfactant protein C (SFTPC) immunohistochemistry (IHC) and semi-quantitative analysis. AEC (primary AT2 cells from WT and MCAT mice and MLE-12 cells) mtDNA damage was assessed by a quantitative PCR-based assay, apoptosis was assessed by DNA fragmentation, and ROS production was assessed by a Mito-Sox assay.
RESULTS: Compared to WT, crocidolite-exposed MCAT mice exhibit reduced pulmonary fibrosis as measured by lung collagen levels and lung fibrosis score. The protective effects in MCAT mice were accompanied by reduced AEC mtDNA damage and apoptosis. Similar findings were noted following bleomycin exposure. Euk-134, a mitochondrial SOD/catalase mimetic, attenuated MLE-12 cell DNA damage and apoptosis. Finally, compared to WT, asbestos-induced MCAT AT2 cell ROS production was reduced.
CONCLUSIONS: Our finding that MCAT mice have reduced pulmonary fibrosis, AEC mtDNA damage and apoptosis following exposure to asbestos or bleomycin suggests an important role for AEC mitochondrial H2O2-induced mtDNA damage in promoting lung fibrosis. We reason that strategies aimed at limiting AEC mtDNA damage arising from excess mitochondrial H2O2 production may be a novel therapeutic target for mitigating pulmonary fibrosis. Published by Elsevier Inc.

Entities:  

Mesh:

Substances:

Year:  2016        PMID: 27840320      PMCID: PMC5928521          DOI: 10.1016/j.freeradbiomed.2016.11.007

Source DB:  PubMed          Journal:  Free Radic Biol Med        ISSN: 0891-5849            Impact factor:   7.376


  63 in total

1.  In situ assessment of oxidant and nitrogenic stress in bleomycin pulmonary fibrosis.

Authors:  Simona Inghilleri; Patrizia Morbini; Tiberio Oggionni; Sergio Barni; Carla Fenoglio
Journal:  Histochem Cell Biol       Date:  2005-11-24       Impact factor: 4.304

2.  PINK1 deficiency impairs mitochondrial homeostasis and promotes lung fibrosis.

Authors:  Marta Bueno; Yen-Chun Lai; Yair Romero; Judith Brands; Claudette M St Croix; Christelle Kamga; Catherine Corey; Jose D Herazo-Maya; John Sembrat; Janet S Lee; Steve R Duncan; Mauricio Rojas; Sruti Shiva; Charleen T Chu; Ana L Mora
Journal:  J Clin Invest       Date:  2014-12-22       Impact factor: 14.808

3.  Bleomycin induces alveolar epithelial cell death through JNK-dependent activation of the mitochondrial death pathway.

Authors:  Vivian Y Lee; Clara Schroedl; Joslyn K Brunelle; Leonard J Buccellato; Ozkan I Akinci; Hideaki Kaneto; Colleen Snyder; James Eisenbart; G R Scott Budinger; Navdeep S Chandel
Journal:  Am J Physiol Lung Cell Mol Physiol       Date:  2005-10       Impact factor: 5.464

Review 4.  Role of mutagenicity in asbestos fiber-induced carcinogenicity and other diseases.

Authors:  Sarah X L Huang; Marie-Claude Jaurand; David W Kamp; John Whysner; Tom K Hei
Journal:  J Toxicol Environ Health B Crit Rev       Date:  2011       Impact factor: 6.393

5.  Redox imbalance and pulmonary function in bleomycin-induced fibrosis in C57BL/6, DBA/2, and BALB/c mice.

Authors:  Marco Aurélio Santos-Silva; Karla Maria Pereira Pires; Eduardo Tavares Lima Trajano; Vanessa Martins; Renata Tiscoski Nesi; Cláudia Farias Benjamin; Maurício Silva Caetano; Cinthya Sternberg; Mariana Nascimento Machado; Walter Araújo Zin; Samuel Santos Valença; Luis Cristóvão Porto
Journal:  Toxicol Pathol       Date:  2012-05-01       Impact factor: 1.902

6.  Mitochondria-targeted catalase reduces abnormal APP processing, amyloid β production and BACE1 in a mouse model of Alzheimer's disease: implications for neuroprotection and lifespan extension.

Authors:  Peizhong Mao; Maria Manczak; Marcus J Calkins; Quang Truong; Tejaswini P Reddy; Arubala P Reddy; Ulziibat Shirendeb; Herng-Hsiang Lo; Peter S Rabinovitch; P Hemachandra Reddy
Journal:  Hum Mol Genet       Date:  2012-04-05       Impact factor: 6.150

7.  The latent form of TGFbeta(1) is induced by TNFalpha through an ERK specific pathway and is activated by asbestos-derived reactive oxygen species in vitro and in vivo.

Authors:  Deborah E Sullivan; Marybeth Ferris; Derek Pociask; Arnold R Brody
Journal:  J Immunotoxicol       Date:  2008-04       Impact factor: 3.000

8.  Macrophage mitochondrial oxidative stress promotes atherosclerosis and nuclear factor-κB-mediated inflammation in macrophages.

Authors:  Ying Wang; Gary Z Wang; Peter S Rabinovitch; Ira Tabas
Journal:  Circ Res       Date:  2013-12-02       Impact factor: 17.367

9.  Attenuation of bleomycin-induced lung injury and oxidative stress by N-acetylcysteine plus deferoxamine.

Authors:  Kelly C Teixeira; Fernanda S Soares; Luís G C Rocha; Paulo C L Silveira; Luciano A Silva; Samuel S Valença; Felipe Dal Pizzol; Emilio L Streck; Ricardo A Pinho
Journal:  Pulm Pharmacol Ther       Date:  2007-08-29       Impact factor: 3.410

10.  Epithelial cell mitochondrial dysfunction and PINK1 are induced by transforming growth factor-beta1 in pulmonary fibrosis.

Authors:  Avignat S Patel; Jin Woo Song; Sarah G Chu; Kenji Mizumura; Juan C Osorio; Ying Shi; Souheil El-Chemaly; Chun Geun Lee; Ivan O Rosas; Jack A Elias; Augustine M K Choi; Danielle Morse
Journal:  PLoS One       Date:  2015-03-18       Impact factor: 3.240

View more
  28 in total

Review 1.  Mitochondria in the spotlight of aging and idiopathic pulmonary fibrosis.

Authors:  Ana L Mora; Marta Bueno; Mauricio Rojas
Journal:  J Clin Invest       Date:  2017-02-01       Impact factor: 14.808

2.  Emerging therapies for idiopathic pulmonary fibrosis, a progressive age-related disease.

Authors:  Ana L Mora; Mauricio Rojas; Annie Pardo; Moises Selman
Journal:  Nat Rev Drug Discov       Date:  2017-10-30       Impact factor: 84.694

3.  Klotho, an antiaging molecule, attenuates oxidant-induced alveolar epithelial cell mtDNA damage and apoptosis.

Authors:  Seok-Jo Kim; Paul Cheresh; Mesut Eren; Renea P Jablonski; Anjana Yeldandi; Karen M Ridge; G R Scott Budinger; Dong-Hyun Kim; Myles Wolf; Douglas E Vaughan; David W Kamp
Journal:  Am J Physiol Lung Cell Mol Physiol       Date:  2017-04-20       Impact factor: 5.464

4.  PGAM5 is a key driver of mitochondrial dysfunction in experimental lung fibrosis.

Authors:  Ingo Ganzleben; Gui-Wei He; Claudia Günther; Elena-Sophie Prigge; Karsten Richter; Ralf J Rieker; Dimitrios Mougiakakos; Markus F Neurath; Christoph Becker
Journal:  Cell Mol Life Sci       Date:  2019-06-05       Impact factor: 9.261

5.  Redox Imbalance in Idiopathic Pulmonary Fibrosis: A Role for Oxidant Cross-Talk Between NADPH Oxidase Enzymes and Mitochondria.

Authors:  Carmen Veith; Agnes W Boots; Musa Idris; Frederik-Jan van Schooten; Albert van der Vliet
Journal:  Antioxid Redox Signal       Date:  2019-04-05       Impact factor: 8.401

6.  SIRT3 deficiency promotes lung fibrosis by augmenting alveolar epithelial cell mitochondrial DNA damage and apoptosis.

Authors:  Renea P Jablonski; Seok-Jo Kim; Paul Cheresh; David B Williams; Luisa Morales-Nebreda; Yuan Cheng; Anjana Yeldandi; Sangeeta Bhorade; Annie Pardo; Moises Selman; Karen Ridge; David Gius; G R Scott Budinger; David W Kamp
Journal:  FASEB J       Date:  2017-03-03       Impact factor: 5.191

7.  Role of phospholipase D in bleomycin-induced mitochondrial reactive oxygen species generation, mitochondrial DNA damage, and pulmonary fibrosis.

Authors:  Vidyani Suryadevara; Longshuang Huang; Seok-Jo Kim; Paul Cheresh; Mark Shaaya; Mounica Bandela; Panfeng Fu; Carol Feghali-Bostwick; Gilbert Di Paolo; David W Kamp; Viswanathan Natarajan
Journal:  Am J Physiol Lung Cell Mol Physiol       Date:  2019-05-15       Impact factor: 5.464

8.  Mitochondrial 8-oxoguanine DNA glycosylase mitigates alveolar epithelial cell PINK1 deficiency, mitochondrial DNA damage, apoptosis, and lung fibrosis.

Authors:  Seok-Jo Kim; Paul Cheresh; Renea P Jablonski; Lyudmila Rachek; Anjana Yeldandi; Raul Piseaux-Aillon; Mark J Ciesielski; Karen Ridge; Cara Gottardi; Anna P Lam; Annie Pardo; Moises Selman; Viswanathan Natarajan; David W Kamp
Journal:  Am J Physiol Lung Cell Mol Physiol       Date:  2020-03-25       Impact factor: 5.464

Review 9.  Emerging therapies for idiopathic pulmonary fibrosis, a progressive age-related disease.

Authors:  Ana L Mora; Mauricio Rojas; Annie Pardo; Moises Selman
Journal:  Nat Rev Drug Discov       Date:  2017-10-06       Impact factor: 84.694

10.  Profibrotic epithelial TGF-β1 signaling involves NOX4-mitochondria cross talk and redox-mediated activation of the tyrosine kinase FYN.

Authors:  Carmen Veith; Milena Hristova; Karamatullah Danyal; Aida Habibovic; Christopher M Dustin; John E McDonough; Bart M Vanaudenaerde; Michael Kreuter; Marc A Schneider; Nicolas Kahn; Frederik J van Schooten; Agnes W Boots; Albert van der Vliet
Journal:  Am J Physiol Lung Cell Mol Physiol       Date:  2020-12-16       Impact factor: 5.464

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.